Dorlixizumab
From Self-sufficiency
Revision as of 13:47, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))
 | This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (September 2009) |
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | Template:Infobox drug/mab source |
| Identifiers | |
| ATC code | none |
Dorlixizumab (proposed USAN) is a chimeric/humanized monoclonal antibody and an immunosuppressive drug.
| 40x30px | This monoclonal antibody-related article is a stub. You can help ssf by expanding it. |
| 40px | This antineoplastic or immunomodulatory drug article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Articles lacking sources from September 2009
- Articles with invalid date parameter in template
- All articles lacking sources
- Articles which use infobox templates with no data rows
- Drugs that are a monoclonal antibody
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Pages with broken file links
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs
